TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Faun Pharma AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
157,133
|
139,658
|
161,928 |
Financial expenses |
594
|
285
|
336 |
Earnings before taxes |
6,334
|
2,829
|
10,855 |
Total assets |
50,227
|
45,605
|
39,288 |
Current assets |
39,722
|
34,091
|
31,917 |
Current liabilities |
10,907
|
11,147
|
13,976 |
Equity capital |
28,488
|
23,515
|
21,319 |
- share capital |
1,000
![]() |
1,000
![]() |
1,000 |
Employees (average) |
41
|
38 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.7%
|
51.6%
|
54.3% |
Turnover per employee |
3,406
|
4,261 | |
Profit as a percentage of turnover |
4.0%
|
2.0%
|
6.7% |
Return on assets (ROA) |
13.8%
|
6.8%
|
28.5% |
Current ratio |
364.2%
|
305.8%
|
228.4% |
Return on equity (ROE) |
22.2%
|
12.0%
|
50.9% |
Change turnover |
17,475
|
-22,270
|
9,273 |
Change turnover % |
13%
|
-14%
|
6% |
Chg. No. of employees | 3 | ||
Chg. No. of employees % | 8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.